3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Other hematologic neoplasm
1
Lymphoid
1
Head & Neck
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
3
Urologic Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Lymphoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia
1
Head and Neck Neoplasms
1
Interventions
pembrolizumab
6
Drug Therapy
3
Cyclophosphamide
3
spartalizumab
2
fludarabine
2
Sirolimus
2
Riluzole
2
Oncolytic Virotherapy
2
Ipilimumab
2
Blood Specimen Collection
2
vofatamab
1
tocilizumab
1
saracatinib
1
poly ICLC
1
pertuzumab
1
pazopanib
1
liposomal doxorubicin
1
ixabepilone
1
fludarabine phosphate
1
enzalutamide
1
durvalumab
1
cediranib
1
brodalumab
1
atezolizumab
1
aldesleukin
1
advexin
1
Ultrasonography
1
Tissue Banks
1
TKM-080301
1
Ritonavir
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Liver Neoplasms
×
Tissue Banks
×
Breast
×
Clear all
NCT06827639
2025-02-14
FUTURE
Assistance Publique Hopitaux De Marseille
Not yet recruiting
640 enrolled